0001209191-18-063590.txt : 20181219 0001209191-18-063590.hdr.sgml : 20181219 20181219195940 ACCESSION NUMBER: 0001209191-18-063590 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181217 FILED AS OF DATE: 20181219 DATE AS OF CHANGE: 20181219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shepard Jay CENTRAL INDEX KEY: 0001587788 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36361 FILM NUMBER: 181244470 MAIL ADDRESS: STREET 1: 15977 GRANDVIEW AVENUE CITY: MONTE SERENO STATE: CA ZIP: 95030 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aravive, Inc. CENTRAL INDEX KEY: 0001513818 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264106690 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: LYONDELLBASELL TOWER STREET 2: 1221 MCKINNEY STREET, SUITE 3200 CITY: HOUSTON STATE: TX ZIP: 77010 BUSINESS PHONE: 936-355-1910 MAIL ADDRESS: STREET 1: LYONDELLBASELL TOWER STREET 2: 1221 MCKINNEY STREET, SUITE 3200 CITY: HOUSTON STATE: TX ZIP: 77010 FORMER COMPANY: FORMER CONFORMED NAME: Versartis, Inc. DATE OF NAME CHANGE: 20110223 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-12-17 0 0001513818 Aravive, Inc. ARAV 0001587788 Shepard Jay C/O ARAVIVE, INC. LYONDELLBASSELL TOWER, 1221 MCKINNEY ST. HOUSTON TX 77010 1 1 0 0 President and CEO Common Stock 2018-12-17 4 S 0 11247 3.962 D 87597 D Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The number of shares reflects the one-for-six reverse stock split effected by Aravive, Inc. on October 16, 2018. /s/ Kevin Haas, Attorney-in-fact 2018-12-19